-
+
Medical BIotechnology
Medical biotechnology is an application of biotechnology that improves the lives of individuals every day. In the medical biotechnology research group, we use state-of-the-art technologies to obtain knowledge applicable in the development of better diagnostics and therapeutics. In addition, we seek knowledge of fundamental biological systems, allowing a better differentiation between disease and normal human development and health.
Focus areas:
- Ageing and age related diseases
- Cancer and circulating tumor cells
- Cardiovascular and heart diseases
- Probiotics and microbiota
- Antibody technology
- Proteases and disease
- Pathological calcium signaling
- Bioactive peptides and secondary metabolites
- Metabolomics
- Novel lead compounds for drug development
Vision
Our research is driven by the ambition of applying science to understand, prevent and treat human diseases.
Collaborations
Within the area of medical biotechnology we collaborate broadly with local and national institutions and experts. These include, but are not limited to, researchers from Faculty of Medicine, AAU and Aalborg University Hospital, Copenhagen University, Herlev Hospital, Danish Technical University, and Aarhus University. Internationally we collaborate with researchers all over the world including Japan, China, Australia, Europe and US.
-
Applied supramolecual chemistry
-
Chemical process engineering
-
Functional genomics
-
Environmental chemical engineering
-
Environmental microbiology
-
Medical biotechnology
-
Environmental bioscience and biomonitoring
-
Biodiversity and evolutionary biology
-
Biorefineries
-
Technological platforms
-
Bioengineering
-
Disordered materials
Contact
Medical Biotechnology
Associate prof. Anders Olsen
Email: ao@bio.aau.dk
Tel.: +45 3069 8155
Geroscience
Ageing and age related diseases, probiotics and microbiota, proteomics and metabolomics, stress responses and apoptosis and molecular motors
Molecular engineering
Cancer and circulating tumor cells, ageing and age related diseases, antibody technology and molecular engineering.
Natural Products Chemistry
Cancer, type 2 diabetes and inflammatory diseases, drugs and lead compounds of natural origin, mechanisms of action, pharmacokinetics, large-scale isolation.
NMR
Biological NMR spectroscopy, cardiovascular and heart diseases, bioactive peptides and secondary metabolites, metabolomics and protein-ligand interactions.
Protein Science
Cardiovascular and heart disease, brown Bear as a translational model, proteases and disease, valorization of industrial protein side streams.
Medical microbiology
Biofilm, diagnosis, treatment and prevention of infection, in vitro and ex vivo models, and health care data.
-
+
Facilities
To be updated
-
+
Business partnerships
A selection of our business partners:
- DuPont
- Novo Nordisk
- MedImmune
- BioY
-
+
People
Geroscience
- Associate Professor Anders Olsen
- PhD student Maria Grymer Metz Mørch
- PhD student Katrine Christensen
- PhD student Rikke Hindsgaul Harders
- Msc student Therese Buhl
- MSc student Lam Thùy Lê
- MSc student Caroline Lund Kidmose
NMR
Protein Science
- Professor Michael Toft Overgaard
- Postdoc Simon Gregersen
- Postdoc Malene Brohus
- Postdoc Helene Halkjær
- PhD student Anne Mette Frøbert
Molecular engineering
- Associate Professor Peter Kristensen
- Postdoc Aida Droce
- MSc student Irene Delgado Alonso
- MSc Student Lærke Andersen
- MSc student Emilie Kjærsgaard
- Student helper Emil Juel Zeuner
Natural product chemistry
Medical microbiology and biotechnology
We are aligned with the following UN Sustainable Development Goals.
